Actuate Therapeutics, Inc. ACTU
0.68
0.06
9.68%
as of 25 Sep
- Market cap
- $15.9M
- P/E
- 0.0×
Follow ACTU
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(296.04%) | (553.75%) | 3,304.93% | 2,457.65% | |
| (150.86%) | (190.35%) | (321.58%) | (336.18%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(217.86%) | (280.07%) | (567.13%) | (2,169.70%) | |
Free Cash Flow per Share |
(0.95) | (0.91) | (0.83) | (0.83) | |
Free Cash Flow |
(20.24) | (19.21) | (19.60) | (19.84) | |
Piotroski F-Score |
3.00 | 3.00 | 3.00 | 3.00 | |
| Other line items | |||||
Cash ROIC |
(72.66%) | (91.10%) | (164.49%) | (366.32%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.84 | 0.86 | 0.91 | 0.97 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.95) | (0.91) | (0.83) | (0.83) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates